Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
12 Suppl
|
| pubmed:dateCreated |
1998-1-2
|
| pubmed:abstractText |
We report the use of two novel nuclide agents, Technetium-99m (99Tc)sestamibi (MIBI) and indium-111 (In-111) octreotide, in comparison with conventional computed tomography (CT) imaging in a patient with metastatic Ewing's sarcoma (ES) before and after high dose chemotherapy with autologous peripheral stem cell transplantation (PSCT). MIBI is taken up actively by metabolically active tumor cells. Octreotide, a somatostatin analog, binds specifically to somatostatin receptors.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Dec
|
| pubmed:issn |
0008-543X
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
15
|
| pubmed:volume |
80
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
2478-83
|
| pubmed:dateRevised |
2011-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:9406698-Adult,
pubmed-meshheading:9406698-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:9406698-Humans,
pubmed-meshheading:9406698-Indium Radioisotopes,
pubmed-meshheading:9406698-Male,
pubmed-meshheading:9406698-Octreotide,
pubmed-meshheading:9406698-Sarcoma, Ewing,
pubmed-meshheading:9406698-Technetium Tc 99m Sestamibi
|
| pubmed:year |
1997
|
| pubmed:articleTitle |
Comparison of Technetium-99m sestamibi and indium-111 octreotide imaging in a patient with Ewing's sarcoma before and after stem cell transplantation.
|
| pubmed:affiliation |
Department of Medicine, Cedars-Sinai Medical Center, University of California Los Angeles School of Medicine, USA.
|
| pubmed:publicationType |
Journal Article,
Comparative Study,
Case Reports
|